首页> 美国卫生研究院文献>Cancer Science >Efficacy of liquid‐based genetic diagnosis of endometrial cancer
【2h】

Efficacy of liquid‐based genetic diagnosis of endometrial cancer

机译:基于液体的子宫内膜癌基因诊断的功效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although liquid‐based cytology (LBC) has increased the sensitivity of cytological diagnosis of endometrial cancer (EC) compared with conventional smear cytology, the sensitivity of LBC for the detection of EC is between 70% and 96% and remains unsatisfactory. In the present study, we compared the efficacy of LBC with liquid‐based genetic diagnosis (LBGDx) by amplicon sequencing of five genes including PTEN,PIK3CA,CTNNB1,KRAS, and TP53 in 48 LBC subjects who underwent endometrial screening. Consequently, LBC classified 15 samples as “positive or suspicious for malignancy” and the 15 were later confirmed as EC. However, LBC failed to identify five cases who were diagnosed as style="fixed-case">EC by additional transvaginal ultrasound and endometrial curettage, indicating that the sensitivity of cytology alone was 75% (15/20). style="fixed-case">LBGDx identified 11 pathogenic style="fixed-case">PTEN variants in 10 subjects, six style="fixed-case">PIK3 style="fixed-case">CA variants in nine, three style="fixed-case">CTNNB1 variants in five, two style="fixed-case">KRAS variants in four, and three style="fixed-case">TP53 variants in three. Collectively, at least one pathogenic variant was identified in 19 subjects, which included 17 style="fixed-case">EC (15 endometrioid carcinoma and 2 endometrial carcinosarcomas), and one cervical adenocarcinoma. However, style="fixed-case">LBGDx did not identify any pathogenic mutations in three of the 20 style="fixed-case">EC, indicating that the sensitivity of style="fixed-case">LBGDx alone was 85% (17/20). Although five style="fixed-case">EC were negative for malignancy by style="fixed-case">LBC and three were negative for pathogenic mutations by style="fixed-case">LBGDx, the combination of style="fixed-case">LBC and style="fixed-case">LBGDx would successfully diagnose all 20 style="fixed-case">EC. These data suggested that style="fixed-case">LBGDx is a useful strategy to improve the sensitivity of screening of style="fixed-case">EC by style="fixed-case">LBC.
机译:尽管与常规涂片细胞学相比,液基细胞学(LBC)提高了子宫内膜癌(EC)的细胞学诊断敏感性,但是LBC对EC的检测灵敏度在70%至96%之间,仍然不令人满意。在本研究中,我们通过对48个接受子宫内膜筛查的LBC受试者中的5个基因(包括PTEN,PIK3CA,CTNNB1,KRAS和TP53)进行扩增子测序,比较了LBC与液基遗传诊断(LBGDx)的疗效。因此,LBC将15个样品分类为“阳性或可疑恶性肿瘤”,然后将15个样品确认为EC。然而,LBC未能通过另外的经阴道超声和子宫内膜刮除术鉴定出5例被诊断为 style =“ fixed-case”> EC 的病例,表明仅细胞学检查的敏感性为75%(15/20) 。 style =“ fixed-case”> LBGD x在10个受试者中鉴定出11种致病性 style =“ fixed-case”> PTEN 变体,其中6个 style =“ fixed-case”> PIK 3 style =“ fixed-case”> CA 变体有九种,三个 style =“ fixed-case”> CTNNB 1变异有五种,两种样式四个版本中的=“ fixed-case”> KRAS 变体,三个版本中的三个 style =“ fixed-case”> TP 53变体。总共在19名受试者中鉴定出至少一种致病变异,其中包括17种 style =“ fixed-case”> EC (15例子宫内膜样癌和2例子宫内膜癌肉瘤)和1例宫颈腺癌。但是, style =“ fixed-case”> LBGD x并未在20个 style =“ fixed-case”> EC 中的三个中识别出任何致病突变,表明仅 style =“ fixed-case”> LBGD x占85%(17/20)。尽管5个 style =“ fixed-case”> EC 对于 style =“ fixed-case”> LBC 对恶性肿瘤呈阴性,而3个对 style =“ fixed-case“> LBGD x, style =” fixed-case“> LBC 和 style =” fixed-case“> LBGD x的组合可以成功诊断全部20个 style =“ fixed-case”> EC 。这些数据表明, style =“ fixed-case”> LBGD x是一种有用的策略,可以提高通过 style筛选 style =“ fixed-case”> EC 的敏感性=“ fixed-case”> LBC

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号